USP EP BP Mushonga Giredhi 148408-66-6 Docetaxel trihydrate Yekurapa Tumor Cancer
Productzita | Docetaxel Trihydrate |
Mashoko anoreva zvakafanana | (αR,βS)-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS) -12b -(acetyloxy) -12-(benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13 ,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,hydrate (1:3) |
CAS Nha. | 148408-66-6 |
Chitarisiko | Ichena kusvika kunze-chena crystalline poda |
Molecular Formula | C43H53NO14.3(H2O) |
Molecular Weight | 861.94 |
Application | Pharma giredhi kana chinangwa chekutsvagisa |
Packing | Sekukumbira kwako |
Storage | Chengetedza mumidziyo yakasimba, isingapindi chiedza munzvimbo inotonhorera |
ZVINHU | MITIRO | RESULTS |
Vanhu | A: Ichena kusvika kune-chena crystalline poda | Conforms |
B:Solubility:Inyungudika mumvura, inonyungudika mu ethanol uye acetone | Conforms | |
SpecificRotation | ﹣38.5°~﹣41.5° | ﹣40° |
Identification | 1.IR: Zvakafanana kutarisa muenzaniso | Conforms |
2.UV: λmax232nm | Conforms | |
| Conforms | |
| Conforms | |
Kusachena | Yese tsvina: NMT 1.0% | 0.29% |
Kusachena A: NMT 0.5% | 0.0551% | |
Kusachena B: NMT 0.3% | 0.0470% | |
Kusachena C: NMT 0.3% | 0.0535% | |
Chero kumwe kusachena kumwe chete: NMT 0.1% | 0.0702% | |
Mvura | 5.0% - 7.0% | 6.15% |
Residue pamoto | NMT 0.1% w/w | 0.03% |
Simbi inorema | NMT 20ppm | Conforms |
Assay | 97.5%~ 102.0% | 99.7% |
Mhedziso | Inosangana neEP7.5. |
Company Information
√ Management layer's yakazara ruzivo mufekitori uye vane hunyanzvi matekinika vateveri; √ Hunhu ndiyo inogara ichitarisisa yedu yepamusoro, Yakasimba QC system; √ makore gumi nerimwe ane ruzivo rwekutengesa kunze timu; √ Yakazvimirira R&D lab; √ Mashopu maviri akasainwa kwenguva refu eGMP; √ Zviwanikwa zvakapfuma zvemafekitori akawanda asina basa epurojekiti yakasarudzika; √ Yakanyanya Kubudirira inoshanda timu ine inowirirana nzira.Nyora meseji yako pano uye titumire kwatiri